Back

PP1 activation as novel antiarrhythmic approach in human heart failure

29 August 2017 (15:35 - 16:25)
Organised by:
Congress Presentation Part of: Cellular and molecular electrophysiology Excitation-contraction coupling and contractile remodelling ESC Premium Access ESC Congress 2017

About the speaker

Photo
Doctor Joerg Eiringhaus

Elbe Clinic Buxtehude, Buxtehude (Germany)

6 More presentations in this session

Presentation thumbnail
Characterization of a novel genetic variant associated with Brugada syndrome: beta-2-syntrophin mutation impairs interaction with SCN5A and reduces Na+ current in human cardiomyocytes
Doctor C. Schmidt (Goettingen, DE)
Abstract
Presentation thumbnail
A mutation in the gene encoding the tbx5 transcription factor is associated with the Brugada Syndrome
Professor R. Caballero (Madrid, ES)
Abstract
Presentation thumbnail
Optogenetic cardioversion terminates atrial fibrillation in wild-type mice after gene transfer
Doctor T. Beiert (Bonn, DE)
Abstract
Presentation thumbnail
Local epicardial light pulse terminates ventricular arrhythmias in the adult rat heart upon optogenetic modification: towards biological shockless defibrillation.
Mr E. Nyns (Rotterdam, NL)
Abstract
Presentation thumbnail
Patient-specific iPSC-derived cardiomyocytes reveal a disease-causing role of an ACTN2 mutation in HCM and an unexpected LQT phenotype
Doctor M. Lemoine (Hamburg, DE)
Abstract

Access the full session

Session thumbnail
Cellular and molecular electrophysiology

The Event

Event poster

ESC Congress 2017

29 August 2017 15:35 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources